These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1703192)

  • 21. Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.
    Lee CW; Lee SF; Halperin SA
    Appl Environ Microbiol; 2004 Aug; 70(8):4569-74. PubMed ID: 15294787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein.
    Lee SF; Halperin SA; Salloum DF; MacMillan A; Morris A
    Infect Immun; 2003 Apr; 71(4):2272-5. PubMed ID: 12654855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii.
    Lee SF; Halperin SA; Knight JB; Tait A
    Appl Environ Microbiol; 2002 Sep; 68(9):4253-8. PubMed ID: 12200273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent.
    Stadnyk AW; Dollard C; Issekutz TB; Issekutz AC
    Gut; 2002 May; 50(5):629-35. PubMed ID: 11950807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
    Hellwig SM; van Spriel AB; Schellekens JF; Mooi FR; van de Winkel JG
    Infect Immun; 2001 Aug; 69(8):4846-50. PubMed ID: 11447159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production.
    Leef M; Elkins KL; Barbic J; Shahin RD
    J Exp Med; 2000 Jun; 191(11):1841-52. PubMed ID: 10839801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii.
    Lee SF; March RJ; Halperin SA; Faulkner G; Gao L
    Infect Immun; 1999 Mar; 67(3):1511-6. PubMed ID: 10024603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-oxo-ETE induces pulmonary eosinophilia in an integrin-dependent manner in Brown Norway rats.
    Stamatiou P; Hamid Q; Taha R; Yu W; Issekutz TB; Rokach J; Khanapure SP; Powell WS
    J Clin Invest; 1998 Dec; 102(12):2165-72. PubMed ID: 9854052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of gamma interferon in natural clearance of Bordetella pertussis infection.
    Barbic J; Leef MF; Burns DL; Shahin RD
    Infect Immun; 1997 Dec; 65(12):4904-8. PubMed ID: 9393774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes.
    Mahon BP; Sheahan BJ; Griffin F; Murphy G; Mills KH
    J Exp Med; 1997 Dec; 186(11):1843-51. PubMed ID: 9382883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation.
    Issekutz TB; Miyasaka M; Issekutz AC
    J Exp Med; 1996 May; 183(5):2175-84. PubMed ID: 8642327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
    Redhead K; Watkins J; Barnard A; Mills KH
    Infect Immun; 1993 Aug; 61(8):3190-8. PubMed ID: 8335349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of B-cell epitopes on the S4 subunit of pertussis toxin.
    Ibsen PH; Holm A; Petersen JW; Olsen CE; Heron I
    Infect Immun; 1993 Jun; 61(6):2408-18. PubMed ID: 7684728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin.
    Petersen JW; Holm A; Ibsen PH; Hasløv K; Heron I
    Infect Immun; 1993 Jan; 61(1):56-63. PubMed ID: 7678102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of antibodies inhibiting the ADP-ribosyltransferase activity of pertussis toxin in human serum.
    Kaslow HR; Platler BW; Blumberg DA; Cherry JD
    J Clin Microbiol; 1992 Jun; 30(6):1380-7. PubMed ID: 1624552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.
    Petersen JW; Holm A; Ibsen PH; Hasløv K; Capiau C; Heron I
    Infect Immun; 1992 Oct; 60(10):3962-70. PubMed ID: 1383145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Bordetella pertussis infection with monoclonal antibodies to pertussis toxin.
    Halperin SA; Issekutz TB; Kasina A
    J Infect Dis; 1991 Feb; 163(2):355-61. PubMed ID: 1703192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope specificity of three anti-pertussis toxin monoclonal antibodies with dissimilar effects in assays of toxin neutralizing activity.
    Halperin SA; Issekutz TB; Kasina A
    Mol Immunol; 1991 Mar; 28(3):247-50. PubMed ID: 1708105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H; Sato Y
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.